Cystic fibrosis may be a rare disease that only affect 30,000 Americans, Cramer concluded, but when the data say that your drug could successfully treat 46% of them, that news is a game changer.
No Huddle OffenseIn his "No Huddle Offense" segment, Cramer said it's time to learn how to love the short-sellers, those stock skeptics that the bulls love to hate. Cramer said that yes, short-sellers can be wrong or early with their doom-and-gloom predictions, but in today's trading, they could have saved investors a bundle.
Cramer said that the short-sellers predicted shortfalls at Fossil, MAKO Surgical (MAKO), Rackspace and Dendreon (DNDN) and all of these companies were hit especially hard as those predictions all came true in spectacular fashion.
Turns out that sometimes the skeptics can be right after all.
--Written by Scott Rutt in Washington, D.C.To contact the writer of this article, click here: Scott Rutt. Follow TheStreet on Twitter and become a fan on Facebook. To submit a news tip, send an email to: email@example.com. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. Click here to sign up for Jim's Daily Booyah to get the Mad Money recap delivered to your inbox.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV